BIOMOTION PHARMA ApS: Financial statements 2012
CVR: 12928203
Source: annual report 2012, Danish Business Authority
01/10/2011 – 30/09/2012
BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 2,550 and a net result of DKK 2,550. Equity in the 2012 report amounted to DKK -1,000.
- Gross Profit
- DKK 2,550
- Profit/Loss
- DKK 2,550
- Equity
- DKK -1,000
- Total Assets
- DKK 0
Official annual report
Keep an eye on BIOMOTION PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of October 15, 2012, Lennie Rasmussen has stepped down as director of BIOMOTION PHARMA ApS.
As of October 15, 2012, Michael Rasmussen is registered as an owner of BIOMOTION PHARMA ApS with an ownership share of 100%.
As of March 28, 2012, JUT NR. 2180 A/S has been appointed auditor of BIOMOTION PHARMA ApS.
As of March 28, 2012, EY Danmark A/S has stepped down as auditor of BIOMOTION PHARMA ApS.
About BIOMOTION PHARMA ApS
BIOMOTION PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company is in liquidation. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Michael Rasmussen. The company is owned by Michael Rasmussen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,000 and a net result of DKK -4,202 compared with DKK -6,460 the year before. Equity in the 2025 report amounted to DKK -892.